$ Value
$0
Shares
4,793
Price
$0
Filed
Jun 9
Insider
Name
GOWEN MAXINE
Title
—
CIK
0001280044
Roles
Transaction Details
Transaction Date
2025-06-06
Code
M
Table
Derivative
Ownership
Direct
Equity Swap
No
Shares After
—
Footnotes
Each restricted stock unit represents a contingent right to receive one share of common stock of the issuer. | The shares subject to this stock option will vest in twelve equal monthly installments commencing on July 5, 2025, subject to the Reporting Person's Continuous Service (as defined in the Plan) through each such vesting date. | This grant was made pursuant to the issuer's tenth amended and restated non-employee director compensation policy. | The shares underlying these restricted stock units will vest in one installment on June 5, 2026, subject to the Reporting Person's Continuous Service (as defined in the Plan) as of such date. | The shares underlying these restricted stock units vested on June 6, 2025.
Filing Info
GOWEN MAXINE's History
| Date | Ticker | Type | Value |
|---|---|---|---|
| 2025-12-12 | MRUS | D | $0 |
| 2025-12-12 | MRUS | D | $0 |
| 2025-12-12 | MRUS | D | $0 |
| 2025-12-12 | MRUS | D | $0 |
| 2025-12-12 | MRUS | D | $0 |
| 2025-12-12 | MRUS | D | $0 |
| 2025-06-06 | ACRS | M | — |
| 2025-06-06 | ACRS | M | $0 |
| 2025-06-05 | ACRS | A | $0 |
| 2025-06-05 | ACRS | A | $0 |
Other Insiders at ACRS (90d)
| Insider | Bought | Sold | Last |
|---|---|---|---|
|
Walker Neal
CEO
|
— | — | 2026-02-03 |
|
Loerop James
Chief Business Officer
|
— | — | 2026-02-03 |
|
Balthaser Kevin
Chief Financial Officer
|
— | — | 2026-02-03 |
|
Davis Hugh M.
President and COO
|
— | — | 2026-02-03 |
|
Hall Jesse Wayne
Chief Medical Officer
|
— | — | 2026-02-02 |
|
Kolbeck Roland Wilhelm
Chief Scientific Officer
|
— | — | 2026-02-02 |